BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Small Cell Lung Cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Staging
62 results:

  • 1. Highly sensitive and simultaneous detection of ctDNAs related to non-small cell lung cancer in serum using a catalytic hairpin assembly strategy in a SERS microfluidic chip.
    Cao X; Mao Y; Gu Y; Ge S; Lu W; Gu Y; Li Z
    J Mater Chem B; 2022 Aug; 10(32):6194-6206. PubMed ID: 35904034
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - Update 2022.
    Gauci ML; Aristei C; Becker JC; Blom A; Bataille V; Dreno B; Del Marmol V; Forsea AM; Fargnoli MC; Grob JJ; Gomes F; Hauschild A; Hoeller C; Harwood C; Kelleners-Smeets N; Kaufmann R; Lallas A; Malvehy J; Moreno-Ramirez D; Peris K; Pellacani G; Saiag P; Stratigos AJ; Vieira R; Zalaudek I; van Akkooi ACJ; Lorigan P; Garbe C; Lebbé C;
    Eur J Cancer; 2022 Aug; 171():203-231. PubMed ID: 35732101
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MUC3A promotes non-small cell lung cancer progression via activating the NFκB pathway and attenuates radiosensitivity.
    Sun Y; Sun X; You C; Ma S; Luo Y; Peng S; Tang F; Tian X; Wang F; Huang Z; Yu H; Xiao Y; Wang X; Zhang J; Gong Y; Xie C
    Int J Biol Sci; 2021; 17(10):2523-2536. PubMed ID: 34326691
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Genetic Mutation Analysis in small cell lung cancer by a Novel NGS-Based Targeted Resequencing Gene Panel and Relation with Clinical Features.
    Jin W; Lei Z; Xu S; Fachen Z; Yixiang Z; Shilei Z; Tao G; Zhe S; Fengzhou L; Su WH; Chundong G
    Biomed Res Int; 2021; 2021():3609028. PubMed ID: 33880365
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. lung adenocarcinoma pathology stages related gene identification.
    Sun GZ; Zhao TW
    Math Biosci Eng; 2019 Oct; 17(1):737-746. PubMed ID: 31731374
    [No Abstract]    [Full Text] [Related]  

  • 7. IL-17F expression correlates with clinicopathologic factors and biological markers in non-small cell lung cancer.
    Li C; Ma X; Tan C; Fang H; Sun Y; Gai X
    Pathol Res Pract; 2019 Oct; 215(10):152562. PubMed ID: 31387805
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Targeted DNA sequencing for assessing clonality in multiple lung tumors: A new approach to an old dilemma.
    Eguren-Santamaria I; Sanchez-Bayona R; Patiño-Garcia A; Gil-Bazo I; Lopez-Picazo JM
    Lung Cancer; 2018 Aug; 122():120-123. PubMed ID: 30032819
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation of CT indicators of NSCLC and pathological features and the expression level of p53 and c-myc.
    Li HS; Lv RQ; Liu L
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):135-141. PubMed ID: 29364480
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. TIGAR is correlated with maximal standardized uptake value on FDG-PET and survival in non-small cell lung cancer.
    Zhou X; Xie W; Li Q; Zhang Y; Zhang J; Zhao X; Liu J; Huang G
    PLoS One; 2013; 8(12):e80576. PubMed ID: 24363807
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Analysis of EGFR, KRAS and p53 mutations in lung cancer using cells in the curette lavage fluid obtained by bronchoscopy.
    Yamaguchi F; Kugawa S; Tateno H; Kokubu F; Fukuchi K
    Lung Cancer; 2012 Dec; 78(3):201-6. PubMed ID: 23026641
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis.
    Qiu Y; Yang H; Chen H; Ge L; Xu X; Xiong X; He J
    Jpn J Clin Oncol; 2010 Feb; 40(2):146-52. PubMed ID: 19897851
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression.
    Han Y; Wang Y; Xu HT; Yang LH; Wei Q; Liu Y; Zhang Y; Zhao Y; Dai SD; Miao Y; Yu JH; Zhang JY; Li G; Yuan XM; Wang EH
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):518-26. PubMed ID: 19735876
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Upregulation of survivin in non-small cell lung cancer and its clinicopathological correlation with p53 and Bcl-2].
    Han PH; Li XJ; Qin H; Yao J; DU N; Ren H
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Aug; 25(8):710-3. PubMed ID: 19664395
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.
    Custodio AB; González-Larriba JL; Bobokova J; Calles A; Alvarez R; Cuadrado E; Manzano A; Díaz-Rubio E
    J Thorac Oncol; 2009 Jul; 4(7):891-910. PubMed ID: 19433989
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer.
    Zhu ZH; Sun BY; Ma Y; Shao JY; Long H; Zhang X; Fu JH; Zhang LJ; Su XD; Wu QL; Ling P; Chen M; Xie ZM; Hu Y; Rong TH
    J Clin Oncol; 2009 Mar; 27(7):1091-9. PubMed ID: 19188679
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. K-RAS and p53 mutations in association with COX-2 and hTERT expression and clinico-pathological status of NSCLC patients.
    Strazisar M; Rott T; Glavac D
    Dis Markers; 2008; 25(2):97-106. PubMed ID: 18957720
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective.
    Dziadziuszko R; Hirsch FR
    Clin Lung Cancer; 2008 Mar; 9(2):78-84. PubMed ID: 18501093
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response.
    Mohamed S; Yasufuku K; Nakajima T; Hiroshima K; Kubo R; Iyoda A; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Farouk A; Fujisawa T
    Thorax; 2008 Jul; 63(7):642-7. PubMed ID: 18390633
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients.
    Chang YL; Wu CT; Lee YC
    J Thorac Cardiovasc Surg; 2007 Sep; 134(3):630-7. PubMed ID: 17723810
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.